firstname.lastname@example.org | +1 (347) 486-4833
United Conference of Anxiety, Depression and Stress Management in Modern Era, focuses on effective treatments for those patients experiencing panic attacks, anxiety attacks, phobia, and social phobia. It gathers various key symptoms of depression and anxiety and tries adapting new conventional methods in the rehabilitation of the disease.
United Conference of Anxiety, Depression and Stress Management in Modern Era is a scientific integrative platform for Mental Health Psychiatrist, Psychologist, Students, Psychiatrist, Research Scholars, Educators, Diagnostic laboratory professionals, Industry Professionals, Business Entrepreneurs, Healthcare Professionals, etc, to share knowledge and research work, recent advancements in the field of Anxiety, Depression and Stress Management.
Owner of Realigner Consulting, Germany
Patient Safety and Pharmacovigilance Analyst at Boehringer Ingelheim, Brazil
Biostatistician II at CTI Clinical Trial and Consulting Services, United States
Associate Director, Safety Operations, Pharmacovigilance and Device Safety Department, Premier Research, Poland.
Director of Operations at ClinEssentials
President And Founder At Sensor Pharma, United States
Director, Head Of External Supply Quality Processes And Development Bei Merck Gruppe Global Quality, Germany
Director, Global Analytical Science & Technology - Pharma & Forensics Bristol Myers Squibb, United States
Executive Director At Ketotic Hypoglycemia International, Committee Member At The European Health Parliament, Patient Representative At The European Medicines Agency, Rare2030 EURORDIS, Europe
Director, Clinical Trial Services At InformedDNA, United States
Managing Director And Co-Founder At Bay Pharma GmbH Greater Kiel Area, Germany
Director & Senior Fellow Pharmaceutical Development, Hospira, A Pfizer Company, United States
Pharmacologist Drug Expert, Associate Professor At Rush Medical College, United States
Founder & CEO, CliniOps, Fremont, California, United States
Founder/CEO At Avril Biopharma, Inc., United States